These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17870554)

  • 1. [Are the NSAIDs able to compromising the cardio-preventive efficacy of aspirin?].
    Flipo RM
    Presse Med; 2006 Sep; 35 Suppl 1():53-60. PubMed ID: 17870554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Are the NSAIDs able to compromising the cardio-preventive efficacy of aspirin?].
    Flipo RM
    Presse Med; 2006 Sep; 35(9 Spec No 1):1S53-60. PubMed ID: 17078596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs--pharmacological mechanisms and clinical relevance.
    Hohlfeld T; Saxena A; Schrör K
    Thromb Haemost; 2013 May; 109(5):825-33. PubMed ID: 23238666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?
    Strand V
    Lancet; 2007 Dec; 370(9605):2138-51. PubMed ID: 18156036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.
    Farkouh ME; Kirshner H; Harrington RA; Ruland S; Verheugt FW; Schnitzer TJ; Burmester GR; Mysler E; Hochberg MC; Doherty M; Ehrsam E; Gitton X; Krammer G; Mellein B; Gimona A; Matchaba P; Hawkey CJ; Chesebro JH;
    Lancet; 2004 Aug 21-27; 364(9435):675-84. PubMed ID: 15325832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.
    García Rodríguez LA; Varas-Lorenzo C; Maguire A; González-Pérez A
    Circulation; 2004 Jun; 109(24):3000-6. PubMed ID: 15197149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial.
    Schnitzer TJ; Burmester GR; Mysler E; Hochberg MC; Doherty M; Ehrsam E; Gitton X; Krammer G; Mellein B; Matchaba P; Gimona A; Hawkey CJ;
    Lancet; 2004 Aug 21-27; 364(9435):665-74. PubMed ID: 15325831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers.
    Gladding PA; Webster MW; Farrell HB; Zeng IS; Park R; Ruijne N
    Am J Cardiol; 2008 Apr; 101(7):1060-3. PubMed ID: 18359332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prescription of NSAIDs in patients treatment with platelet inhibitors or anticoagulants].
    Avouac B; Combe B; Darné B
    Presse Med; 2003 Nov; 32(37 Pt 2):S38-43. PubMed ID: 14763353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative antiplatelet activity of COX1 NSAIDS versus aspirin, encompassing regimen simplification and gastroprotection: a call for a controlled study.
    Rothschild BM
    Reumatismo; 2004; 56(2):89-93. PubMed ID: 15309216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiovascular toxicity of selective and nonselective cyclooxygenase inhibitors: comparisons, contrasts, and aspirin confounding.
    Konstantinopoulos PA; Lehmann DF
    J Clin Pharmacol; 2005 Jul; 45(7):742-50. PubMed ID: 15951464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study.
    Rahme E; Nedjar H; Bizzi A; Morin S
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1387-98. PubMed ID: 17892525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective effects of aspirin compromised by other NSAIDs.
    Gottlieb S
    BMJ; 2003 Sep; 327(7414):520. PubMed ID: 12958094
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets.
    Saxena A; Balaramnavar VM; Hohlfeld T; Saxena AK
    Eur J Pharmacol; 2013 Dec; 721(1-3):215-24. PubMed ID: 24075938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of non-steroidal anti-inflammatory drugs on antiplatelet effect of aspirin.
    Yokoyama H; Ito N; Soeda S; Ozaki M; Suzuki Y; Watanabe M; Kashiwakura E; Kawada T; Ikeda N; Tokuoka K; Kitagawa Y; Yamada Y
    J Clin Pharm Ther; 2013 Feb; 38(1):12-5. PubMed ID: 22882748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ibuprofen on the magnitude and duration of aspirin's inhibition of platelet aggregation: clinical consequences in stroke prophylaxis.
    Gengo FM; Rubin L; Robson M; Rainka M; Gengo MF; Mager DE; Bates V
    J Clin Pharmacol; 2008 Jan; 48(1):117-22. PubMed ID: 18094224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib.
    Farkouh ME; Greenberg JD; Jeger RV; Ramanathan K; Verheugt FW; Chesebro JH; Kirshner H; Hochman JS; Lay CL; Ruland S; Mellein B; Matchaba PT; Fuster V; Abramson SB
    Ann Rheum Dis; 2007 Jun; 66(6):764-70. PubMed ID: 17412741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
    Angiolillo DJ; Hwang C; Datto C; Desai B; Sostek M
    Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.